Posts by John

A recent clinical trial explores whether psilocybin-assisted therapy can help patients with anorexia overcome cognitive rigidity and seek recovery.

Discover how a transparent, data-driven approach is transforming vaccine trial recruitment to improve subject diversity and boost clinical trial efficacy.

Scholar Rock’s apitegromab filing highlights critical risks in CMO due diligence. Learn why proactive manufacturer oversight is essential for clinical success.

AI in drug discovery is racing to Phase I, but experts argue true success lies in late-stage results. Learn why clinical efficacy is the real goal.

Discover how strategic collaborations and digital innovation are transforming clinical trial success rates, speeding up drug development, and boosting RWE.

Researchers identify key mechanisms of resistance to the RAS inhibitor daraxonrasib, paving the way for new, highly effective combination cancer therapies.

Discover how next-gen B-cell depletion therapies are reshaping CNS autoimmune research and setting a new gold standard for regulatory approval processes.

Tenax Therapeutics releases Phase 3 LEVEL trial data for TNX-103 in PH-HFpEF patients. Discover the key clinical outcomes for this potential new therapy.

New dosimetry data for Radspherin offers a breakthrough in treating peritoneal metastases, highlighting the potential of targeted alpha-emitter therapy.

Kodiak Sciences has started its Phase 3 ALTO trial for KSI-501. Discover how this bispecific drug aims to transform Diabetic Macular Edema treatment.